Anna Lou-Hing
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Anna Lou-Hing has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Edward L. Bolt
School of Life Sciences, University of Nottingham
3 shared publications - Ashley J. Parkes
School of Life Sciences, University of Nottingham, U.K.
1 shared publication - Christian J. Rudolph
Division of Biosciences, Department of Life Sciences, Centre for Genome Engineeringand Maintenance, College of Health, Medicine and Life Sciences, Brunel University London, Uxbridge, UK
1 shared publication Fiona Kemm
School of Life Sciences, University of Nottingham , NG7 2UH
1 shared publication- Fiorela Kapllanaj
School of Life Sciences, University of Nottingham
1 shared publication - Ivana Ivančić-Baće
Faculty of Science, University of Zagreb, 10000 Zagreb, Croatia
1 shared publication
Latest Publications
- Open Access
- 8 June 2026
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 54 (11)
Visualizing the interplay of Cas1–Cas2 with DNA replication-repair that creates CRISPR–Cas immunity
Prokaryotic CRISPR–Cas systems rely on the Cas1–Cas2 protein complex to capture new DNA from mobile genetic elements (MGEs), to form immunological memory that defends against the MGEs. However, the mechanisms by which Cas1–Cas2 locates suitable DNA substrates inside cells remain unclear, limiting our understanding of how CRISPR–Cas immunity arises de novo. We directly visualized functional, DNA-bound Cas1–Cas2 complexes in bacteria, revealing the processes that license Cas1–Cas2 to capture DNA. Visible DNA-bound Cas1–Cas2 complexes formed only when replisomes are actively advancing, accumulating at post-replicative DNA gaps behind replication forks—structures arising during normal genome duplication, which are normally repaired by homologous recombination. Replication stress, which increases replicative DNA gap frequency, enhanced visible Cas1–Cas2 DNA binding. DNA capture by Cas1–Cas2 was strongly stimulated in cells lacking the RecFOR complex, which normally directs DNA gaps to repair. The RecBCD recombination initiator complex was essential for DNA capture by Cas1–Cas2 in these cells. The findings support a model in which naïve CRISPR–Cas adaptation is licensed by abundant replication-dependent DNA repair intermediates, prior to their repair by recombination. This identifies the mechanism co-ordinating Cas1–Cas2 with essential DNA replication and repair processes that all cells need, including when they are hijacked to replicate parasitic MGEs.
- 8 June 2026
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 54 (11)
Open AccessVisualizing the interplay of Cas1–Cas2 with DNA replication-repair that creates CRISPR–Cas immunity
Prokaryotic CRISPR–Cas systems rely on the Cas1–Cas2 protein complex to capture new DNA from mobile genetic elements (MGEs), to form immunological memory that defends against the MGEs. However, the mechanisms by which Cas1–Cas2 locates suitable DNA substrates inside cells remain unclear, limiting our understanding of how CRISPR–Cas immunity arises de novo. We directly visualized functional, DNA-bound Cas1–Cas2 complexes in bacteria, revealing the processes that license Cas1–Cas2 to capture DNA. Visible DNA-bound Cas1–Cas2 complexes formed only when replisomes are actively advancing, accumulating at post-replicative DNA gaps behind replication forks—structures arising during normal genome duplication, which are normally repaired by homologous recombination. Replication stress, which increases replicative DNA gap frequency, enhanced visible Cas1–Cas2 DNA binding. DNA capture by Cas1–Cas2 was strongly stimulated in cells lacking the RecFOR complex, which normally directs DNA gaps to repair. The RecBCD recombination initiator complex was essential for DNA capture by Cas1–Cas2 in these cells. The findings support a model in which naïve CRISPR–Cas adaptation is licensed by abundant replication-dependent DNA repair intermediates, prior to their repair by recombination. This identifies the mechanism co-ordinating Cas1–Cas2 with essential DNA replication and repair processes that all cells need, including when they are hijacked to replicate parasitic MGEs.
- Open Access
- 18 December 2024
- Published by The Royal Society in Royal Society Open Science
- Vol. 11 (12) , 241891
Identification of a novel nuclease activity in human DDX49 helicase
Human DDX49 is an emerging target in cancer progression and retroviral diseases through its essential roles in nucleolar RNA processing. Here, we identify nuclease activity of human DDX49, which requires active site aspartate residues within a conserved region of metazoan DDX49s that is absent from yeast and archaeal DDX49 homologues. We provide evidence that DDX49 nuclease activity is facilitated by its helicase activity. Using CRISPR-Cas9 genetic editing, we show that a heterozygous ( DDX49 +/− ) U2OS cell line is defective at cell migration, a phenotype supporting the association of DDX49 with cancer cell invasiveness. Measurement of RNAs in DDX49 +/− indicates that DDX49 is required to sustain levels of 5.8S rRNA.
- 18 December 2024
- Published by The Royal Society in Royal Society Open Science
- Vol. 11 (12) , 241891
Open AccessIdentification of a novel nuclease activity in human DDX49 helicase
Human DDX49 is an emerging target in cancer progression and retroviral diseases through its essential roles in nucleolar RNA processing. Here, we identify nuclease activity of human DDX49, which requires active site aspartate residues within a conserved region of metazoan DDX49s that is absent from yeast and archaeal DDX49 homologues. We provide evidence that DDX49 nuclease activity is facilitated by its helicase activity. Using CRISPR-Cas9 genetic editing, we show that a heterozygous ( DDX49 +/− ) U2OS cell line is defective at cell migration, a phenotype supporting the association of DDX49 with cancer cell invasiveness. Measurement of RNAs in DDX49 +/− indicates that DDX49 is required to sustain levels of 5.8S rRNA.
- Open Access
- 19 November 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (22) , 12417
POLD3 as Controller of Replicative DNA Repair
Multiple modes of DNA repair need DNA synthesis by DNA polymerase enzymes. The eukaryotic B-family DNA polymerase complexes delta (Polδ) and zeta (Polζ) help to repair DNA strand breaks when primed by homologous recombination or single-strand DNA annealing. DNA synthesis by Polδ and Polζ is mutagenic, but is needed for the survival of cells in the presence of DNA strand breaks. The POLD3 subunit of Polδ and Polζ is at the heart of DNA repair by recombination, by modulating polymerase functions and interacting with other DNA repair proteins. We provide the background to POLD3 discovery, investigate its structure, as well as function in cells. We highlight unexplored structural aspects of POLD3 and new biochemical data that will help to understand the pivotal role of POLD3 in DNA repair and mutagenesis in eukaryotes, and its impact on human health.
- 19 November 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (22) , 12417
Open AccessPOLD3 as Controller of Replicative DNA Repair
Multiple modes of DNA repair need DNA synthesis by DNA polymerase enzymes. The eukaryotic B-family DNA polymerase complexes delta (Polδ) and zeta (Polζ) help to repair DNA strand breaks when primed by homologous recombination or single-strand DNA annealing. DNA synthesis by Polδ and Polζ is mutagenic, but is needed for the survival of cells in the presence of DNA strand breaks. The POLD3 subunit of Polδ and Polζ is at the heart of DNA repair by recombination, by modulating polymerase functions and interacting with other DNA repair proteins. We provide the background to POLD3 discovery, investigate its structure, as well as function in cells. We highlight unexplored structural aspects of POLD3 and new biochemical data that will help to understand the pivotal role of POLD3 in DNA repair and mutagenesis in eukaryotes, and its impact on human health.